在老鼠ALS/FTLD模型中,具有不同聚合性质的TDP-43突变体表现出明显的毒性,轴突运输和疾病进展的分泌
Hideki Mori1, Tokiharu Sato2, Shintaro Tsuboguchi1
1Department of Neurology, Brain Research Institute, Niigata University, Niigata, Niigata 951-8585, Japan.
Neurobiology of disease
|June 7, 2025
概括
不同的TDP-43突变在ALS和FTLD中引起了不同的神经退行性事件. 倾向于聚合的TDP-43形成了入,而不易发生突变的突变会导致严重的细胞死亡和轴突退化,影响疾病的进展.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- TDP-43蛋白聚合是神经退行性疾病的标志,如肌缩侧面硬化症 (ALS) 和前叶退化症 (FTLD).
- 在ALS/FTLD患者中的多样性病理表现表明TDP-43包容的不同作用,但确切的机制仍然不清楚.
研究的目的:
- 研究具有不同聚合性质的TDP-43突变如何影响神经退行过程.
- 为了比较在神经和质细胞中易聚与易不聚的TDP-43突变物引起的不同病理事件.
主要方法:
- 利用培养的神经元和小鼠大脑皮层模型.
- 比较了TDP-43C173/175S (容易聚合) 和TDP-43G298S (不容易) 突变物.
- 评估了包容形成,细胞死亡,轴突运输,外体分泌和细胞间转移.
主要成果:
- TDP-43C173/175S强烈形成了细胞质内含物,而TDP-43G298S诱导了更严重的细胞死亡.
- TDP-43G298S表现出高效的轴突运输和退化,而TDP-43C173/175S则被困在轴突初始段中.
- TDP-43G298S在外体中被更有效地分泌,转移到寡干细胞中,并诱导微质细胞因子反应.
结论:
- 独特的TDP-43聚合特性导致神经退行症的不同病理结果.
- 这些发现提供了对ALS和FTLD患者观察到的可变疾病进展和分布模式的见解.
相关概念视频
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...